Stocks and Investing
Stocks and Investing
Tue, November 6, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 5, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alex Arfaei Maintained (ABBV) at Sell with Decreased Target to $71 on, Nov 5th, 2018
Alex Arfaei of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Sell with Decreased Target from $78 to $71 on, Nov 5th, 2018.
Alex has made no other calls on ABBV in the last 4 months.
There is 1 other peer that has a rating on ABBV. Out of the 1 peers that are also analyzing ABBV, 0 agree with Alex's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alex
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $106 on, Thursday, October 4th, 2018